Related Experiment Video
Updated: Jul 13, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
[Pathophysiology of kidney disease progression]
Thierry Krummel1, Dorothée Bazin, Thierry Hannedouche
1Service de néphrologie, Hôpitaux universitaires de Strasbourg.
Nephron reduction initially boosts filtration but causes long-term kidney damage by activating the renin-angiotensin system and TGF-beta, leading to fibrosis. Inhibitors of these pathways are crucial for managing kidney disease.
Area of Science:
- Nephrology
- Renal Physiology
- Pathology
Context:
- Nephron reduction, a common feature in chronic kidney disease, presents a paradox.
- Compensatory hyperfiltration in remaining nephrons offers short-term benefits but initiates detrimental long-term processes.
Purpose:
- To elucidate the long-term consequences of nephron reduction on renal health.
- To explore the molecular mechanisms linking nephron loss to kidney fibrosis.
- To highlight therapeutic strategies targeting the renin-angiotensin system.
Summary:
- Nephron reduction leads to increased glomerular pressure and hypertrophy, activating the renin-angiotensin system and TGF-beta.
- This activation promotes myofibroblastic transdifferentiation, fibrogenesis, and glomerulosclerosis.
- Converting enzyme inhibitors mitigate profibrotic gene expression, while blocking the renin-angiotensin system is vital for reducing proteinuria and interstitial fibrosis.
Impact:
- Understanding these mechanisms is key to developing targeted therapies for chronic kidney disease.
- Reducing proteinuria and fibrosis can slow disease progression and preserve renal function.
- This research underscores the importance of managing the renin-angiotensin system in nephron-deficient states.
More Related Videos
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Related Concept Videos
Chronic Kidney Disease I: Introduction
Diabetic Nephropathy
Acute Kidney Injury II: Pathophysiology
Nephrons
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations